NASDAQ: GRDX
Gridai Technologies Corp Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their GRDX stock forecasts and price targets.

Forecast return on equity

Is GRDX forecast to generate an efficient return?

Company
-25.04%
Industry
79.27%
Market
345.74%
GRDX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GRDX forecast to generate an efficient return on assets?

Company
-4.18%
Industry
23.89%
GRDX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GRDX earnings per share forecast

What is GRDX's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.55
Avg 2 year Forecast
-$1.77
Avg 3 year Forecast
-$1.68

GRDX revenue forecast

What is GRDX's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

GRDX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GRDX$2.48N/AN/A
GTBP$0.78N/AN/A
RNAZ$9.29N/AN/A
BGMS$1.66N/AN/A
SLXN$2.76N/AN/A

Gridai Technologies Stock Forecast FAQ

What is GRDX's earnings growth forecast for 2025-2027?

(NASDAQ: GRDX) Gridai Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 75.19%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 105.65%.

Gridai Technologies's earnings in 2025 is -$15,993,330.On average, 3 Wall Street analysts forecast GRDX's earnings for 2025 to be -$5,212,294, with the lowest GRDX earnings forecast at -$5,007,891, and the highest GRDX earnings forecast at -$5,365,597. On average, 3 Wall Street analysts forecast GRDX's earnings for 2026 to be -$5,966,705, with the lowest GRDX earnings forecast at -$5,732,717, and the highest GRDX earnings forecast at -$6,142,197.

In 2027, GRDX is forecast to generate -$5,658,083 in earnings, with the lowest earnings forecast at -$5,436,197 and the highest earnings forecast at -$5,824,497.

If you're new to stock investing, here's how to buy Gridai Technologies stock.

What is GRDX's revenue growth forecast for 2025-2027?

(NASDAQ: GRDX) Gridai Technologies's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 287.93%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.73%.

Gridai Technologies's revenue in 2025 is $0.On average, 3 Wall Street analysts forecast GRDX's revenue for 2025 to be $0, with the lowest GRDX revenue forecast at $0, and the highest GRDX revenue forecast at $0. On average, 3 Wall Street analysts forecast GRDX's revenue for 2026 to be $0, with the lowest GRDX revenue forecast at $0, and the highest GRDX revenue forecast at $0.

In 2027, GRDX is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is GRDX's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: GRDX) forecast ROA is -4.18%, which is lower than the forecast US Biotechnology industry average of 23.89%.

What is GRDX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: GRDX) Gridai Technologies's current Earnings Per Share (EPS) is -$12.22. On average, analysts forecast that GRDX's EPS will be -$1.55 for 2025, with the lowest EPS forecast at -$1.49, and the highest EPS forecast at -$1.60. On average, analysts forecast that GRDX's EPS will be -$1.77 for 2026, with the lowest EPS forecast at -$1.71, and the highest EPS forecast at -$1.83. In 2027, GRDX's EPS is forecast to hit -$1.68 (min: -$1.62, max: -$1.73).

What is GRDX's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: GRDX) forecast ROE is -25.04%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.